Concepedia

Kathy D. Miller

KD

Statistics

Publications

220

Citations

22.2K

H-Index

72

Active since

1977

Affiliations

Indiana University – Purdue University Indianapolis(Current)

Indiana University School of Medicine

Indiana University Health

Dana-Farber Cancer Institute

Memorial Sloan Kettering Cancer Center

Kathy D. Miller is an author at Indiana University – Purdue University Indianapolis specializing in medicine, oncology, and pharmacology.

ORCID

Publications per year

1977–2025

220

Publications

220

Paclitaxel plus Bevacizumab versus Paclitaxel Alone for Metastatic Breast Cancer

Kathy D. Miller, Molin Wang, Julie R. Gralow et al. · New England Journal of Medicine · 2007 · 3.1K citations · Full text

, , +13

Randomized Phase III Trial of Capecitabine Compared With Bevacizumab Plus Capecitabine in Patients With Previously Treated Metastatic Breast Cancer

Kathy D. Miller, Linnea Chap, Frankie A. Holmes et al. · Journal of Clinical Oncology · 2005 · 1.3K citations · Full text

, , +17

NF-κ B Promotes Breast Cancer Cell Migration and Metastasis by Inducing the Expression of the Chemokine Receptor CXCR4

Gregory M. Helbig, Kent W. Christopherson, Poornima Bhat‐Nakshatri et al. · Journal of Biological Chemistry · 2003 · 635 citations · Full text

, , +14

Association of Vascular Endothelial Growth Factor and Vascular Endothelial Growth Factor Receptor-2 Genetic Polymorphisms With Outcome in a Trial of Paclitaxel Compared With Paclitaxel Plus Bevacizumab in Advanced Breast Cancer: ECOG 2100

Bryan P. Schneider, Milan Radovich, George W. Sledge et al. · Journal of Clinical Oncology · 2008 · 608 citations · Full text

, , +17

Enzalutamide for the Treatment of Androgen Receptor–Expressing Triple-Negative Breast Cancer

Tiffany A. Traina, Kathy D. Miller, Denise A. Yardley et al. · Journal of Clinical Oncology · 2018 · 519 citations · Full text

, , +17

1–5 of 220